Golden Biotechnology Revenue vs. Gross Profit
| 4132 Stock | TWD 16.55 0.45 2.65% |
For Golden Biotechnology profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Golden Biotechnology to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Golden Biotechnology utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Golden Biotechnology's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Golden Biotechnology over time as well as its relative position and ranking within its peers.
Golden |
Golden Biotechnology Gross Profit vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Golden Biotechnology's current stock value. Our valuation model uses many indicators to compare Golden Biotechnology value to that of its competitors to determine the firm's financial worth. Golden Biotechnology is rated second in revenue category among its peers. It also is rated second in gross profit category among its peers fabricating about 0.65 of Gross Profit per Revenue. The ratio of Revenue to Gross Profit for Golden Biotechnology is roughly 1.53 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Golden Biotechnology's earnings, one of the primary drivers of an investment's value.Golden Revenue vs. Competition
Golden Biotechnology is rated second in revenue category among its peers. Market size based on revenue of Drug Manufacturers - Specialty & Generic industry is presently estimated at about 25.99 Billion. Golden Biotechnology adds roughly 78.35 Million in revenue claiming only tiny portion of equities under Drug Manufacturers - Specialty & Generic industry.
Golden Gross Profit vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Golden Biotechnology |
| = | 78.35 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Golden Biotechnology |
| = | 51.31 M |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Golden Gross Profit Comparison
Golden Biotechnology is number one stock in gross profit category among its peers.
Golden Biotechnology Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Golden Biotechnology, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Golden Biotechnology will eventually generate negative long term returns. The profitability progress is the general direction of Golden Biotechnology's change in net profit over the period of time. It can combine multiple indicators of Golden Biotechnology, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Golden Biotechnology Corporation operates as a drug discovery and healthy food supplement manufacturing company. Golden Biotechnology Corporation was founded in 2002 and is based in New Taipei City, Taiwan. GOLDEN BIOTECHNOLOGY operates under Drug Manufacturers - Specialty Generic classification in Taiwan and is traded on Taiwan OTC Exchange. It employs 135 people.
Golden Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Golden Biotechnology. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Golden Biotechnology position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Golden Biotechnology's important profitability drivers and their relationship over time.
Use Golden Biotechnology in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Golden Biotechnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Golden Biotechnology will appreciate offsetting losses from the drop in the long position's value.Golden Biotechnology Pair Trading
Golden Biotechnology Pair Trading Analysis
The ability to find closely correlated positions to Golden Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Golden Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Golden Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Golden Biotechnology to buy it.
The correlation of Golden Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Golden Biotechnology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Golden Biotechnology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Golden Biotechnology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Golden Biotechnology position
In addition to having Golden Biotechnology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Plastics Thematic Idea Now
Plastics
Companies manufacturing rubber and plastics accessories. The Plastics theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Plastics Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Golden Stock Analysis
When running Golden Biotechnology's price analysis, check to measure Golden Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Golden Biotechnology is operating at the current time. Most of Golden Biotechnology's value examination focuses on studying past and present price action to predict the probability of Golden Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Golden Biotechnology's price. Additionally, you may evaluate how the addition of Golden Biotechnology to your portfolios can decrease your overall portfolio volatility.